Last reviewed · How we verify
Beta-blockers including Carvedilol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Beta-blockers including Carvedilol (Beta-blockers including Carvedilol) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Beta-blockers including Carvedilol TARGET | Beta-blockers including Carvedilol | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Beta-blockers including Carvedilol CI watch — RSS
- Beta-blockers including Carvedilol CI watch — Atom
- Beta-blockers including Carvedilol CI watch — JSON
- Beta-blockers including Carvedilol alone — RSS
Cite this brief
Drug Landscape (2026). Beta-blockers including Carvedilol — Competitive Intelligence Brief. https://druglandscape.com/ci/beta-blockers-including-carvedilol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab